Abstract

ObjectivesThe present study aimed to (i) investigate biocompatibility and cytotoxicity of pulp capping materials on viability of hDPSCs, (ii) determine angiogenic, odontogenic, and osteogenic marker mRNA expressions, and (iii) observe changes in surface morphology of the hDPSCs using SEM. MethodsImpacted third molars were used to isolate the hDPSCs, which were treated with extract release fluids of the pulp capping materials (Harvard BioCal–Cap, NeoPutty MTA, TheraCal LC, and Dycal). Effects of the capping materials on cell viability were assessed using MTS assay and the apoptotic/necrotic cell ratios and ROS levels from a flow cytometry. Marker expressions (ALP, OCN, Col1A, SPARC (ON) and VEGF) were determined by RT-qPCR. Changes in surface morphology of the hDPSCs were visualized by SEM. ResultsThe MTS assay results at days 1, 3, 5 and 7 indicated that Harvard BioCal–Cap, NeoPutty MTA and TheraCal LC did not adversely affect cell viability when compared to the control group. According to the MTS assay results at day 14, no significant difference was found among Dycal, Harvard BioCal–Cap, NeoPutty MTA and TheraCal LC affecting the cell viability. Dycal was the only capping material that increases the ROS level. High levels of VEGF expression were observed in Harvard BioCal-Cap, TheraCal LC, and NeoPutty MTA. NeoPutty MTA and Dycal up-regulated OCN expression, whereas TheraCal LC up-regulated Col1A and SPARC expression. Only Dycal increased ALP expression. The hDPSCs were visualized in characteristic spindle morphology by SEM due to TheraCal LC and Harvard BioCal–Cap. ConclusionsNeoPutty MTA and Harvard BioCal–Cap showed suitable biocompatibility values, and in particular, these pulp capping materials were observed to support the angiogenic marker. Clinical SignificanceSince it was thought that cytotoxicity and biocompatibility values would contribute significantly to future studies, a new pulp capping material, NeoPutty MTA and Harvard BioCal-Cap, were used in this study.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call